Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model
Science Translational Medicine · 16.04.2025 · 17 (794)
DOI: 10.1126/scitranslmed.adq2005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 16.04.2025. Verfasst von Takayoshi Imai und 8 weiteren Autor:innen. Beteiligte Einrichtung: EditForce Inc., Fukuoka 819-0395, Japan. Hauptthemen laut MEDLINE: Myotonic Dystrophy, RNA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Myotonic dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder caused by the expansion of a CTG-triplet repeat in the 3′ untranslated region of the dystrophia myotonica protein kinase ( DMPK ) gene. It results in the transcription of toxic RNAs that contain expanded CUG repeats (CUG exp ). Splicing factors, such as muscleblind-like 1 (MBNL1), are sequestered by CUG exp , thereby disrupting the normal splicing program that is essential for various cellular functions. Pentatricopeptide repeat (PPR) proteins, originally found in plants, regulate RNA in organelles by binding in a sequence-specific manner. Here, we designed PPR proteins that specifically bind to the hexamer of CUG repeat RNAs (CUG-PPRs) and showed that CUG-PPR1 could ameliorate RNA toxicity induced by CUG exp in cell models of DM1. A single systemic recombinant adeno-associated virus (AAV9) vector–mediated gene delivery of CUG-PPR1 demonstrated long-term therapeutic effects on myotonia and restored splicing activity in a mouse model of DM1. These results highlight the potential of PPR molecules to target pathogenic RNA sequences in DM1 and potentially other RNA-mediated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- EditForce Inc., Fukuoka 819-0395, Japan.
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
- Department of Neurology, Yamaguchi University Graduate School of Medicine, Ube 755-8505, Japan.
- Faculty of Agriculture, Kyushu University, Fukuoka 819-0395, Japan.
ORCID-Profile: Takayoshi Imai, Joe Nemoto, Masaru Ohta, Yusuke Yagi, Osamu Nakanishi, Masayuki Nakamori
Zitieren
APA
Imai, T., Miyai, M., Nemoto, J., Tamai, T., Ohta, M., Yagi, Y., Nakanishi, O., Mochizuki, H., & Nakamori, M. (2025). Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model. Science Translational Medicine, 17(794). https://doi.org/10.1126/scitranslmed.adq2005
Vancouver
Imai T, Miyai M, Nemoto J, Tamai T, Ohta M, Yagi Y, et al. Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model. Science Translational Medicine. 2025;17(794). doi:10.1126/scitranslmed.adq2005
BibTeX
@article{Imai2025,
author = {Imai, Takayoshi and Miyai, Maiko and Nemoto, Joe and Tamai, Takayuki and Ohta, Masaru and Yagi, Yusuke and Nakanishi, Osamu and Mochizuki, Hideki and Nakamori, Masayuki},
title = {Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {794},
doi = {10.1126/scitranslmed.adq2005}
}
EUVIMED